Temporal Pattern of Circulating DNA for Patients Receiving Irradiation
NCT ID: NCT01099020
Last Updated: 2015-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
13 participants
OBSERVATIONAL
2010-04-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Alterations of DNA in Human Blood
NCT00178308
Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points
NCT02297009
To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks
NCT02377609
Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation
NCT02226874
Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)
NCT01818154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must be willing to have blood draws as defined below.
* Patient must provide study-specific informed consent prior to study entry.
* Hemoglobin≥8.
* Age ≥ 18, but not older than age 60.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rochester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Milano, MD,PhD
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rochester
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ULAB10008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.